RePORT International What’s New

“Defeating Tuberculosis: An Adventure with Learning” is an educational booklet designed for children, presenting essential information about tuberculosis in a playful and interactive way. This English version was adapted from the original publication in Portuguese. The material introduces basic concepts of microbiology, highlighting the differences between viruses, bacteria, and fungi, and teaches key prevention measures such as vaccination and the importance of hygiene. Through interactive activities — including games, coloring pages, and challenges — the booklet encourages children to learn about TB symptoms, the importance of early diagnosis, and the role of health professionals in treatment. At the end, children receive a “Little Health Scientist Certificate”, reinforcing the message that everyone can contribute to the prevention and elimination of tuberculosis.

The call for conference projects and publications covers all the thematic fields of the agency: - All research on HIV/AIDS, sexually transmitted infections (STIs), viral hepatitis, tuberculosis, including research on their co-infections; - Research on emerging and re-emerging infectious diseases, including arboviruses, respiratory viruses and viral hemorrhagic fevers. It is now possible to submit an application for funding continuously throughout the year, according to the following forecast schedule: January 15 – April 30 May 1 – August 31 September 1 – December 15

The Workshop will be held as a hybrid meeting from 4-5 December 2025, in San Francisco, US. The deadline for abstract submission is 5 September 2025.

APPLICATION DEADLINE: 1 December, 2025 11:59 p.m. ET The American Lung Association Catalyst Award is a mentored award meant to support outstanding investigators on the path to independence for research into the mechanisms of lung disease and general lung biology. Preference is given to projects that are novel, innovative in design/approach, utilize modern technologies, and incorporate a multidisciplinary collaborative training plan. The Catalyst Grant is for $50,000 per year, for up to two years. Grants are subject to annual review; the second year of support is based upon demonstration of satisfactory progress. When applicable, researchers are encouraged to investigate hypothesis‐driven research that will inform evidence‐based clinical practice or policy in communities across the United States. Proposals can include examining the cause and prevention of lung diseases like tuberculosis, asthma, COPD, and lung cancer, as well as management of lung disease.

Dealine for New Application: 25 November, 2025 This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

The purpose of this notice of funding opportunity (NOFO) is to support the establishment of multidisciplinary Tuberculosis (TB) Research Units (TBRUs) that will operate as a collaborative network to improve understanding of Mycobacterium tuberculosis (Mtb)-host interactions through characterizing the roles of bacterial and host heterogeneity on infection outcomes and disease progression, and defining bacterial and host determinants relevant to Mtb establishment, dissemination, and disease stage. Please refer to the website for detail announcement and key dates.

APPLICATION DEADLINE: 05 November 2025 17:00:00 Brussels time Objective: The aim is to provide support for a small group of two to four Principal Investigators to jointly address ambitious research problems that could not be addressed by the individual Principal Investigators and their teams working alone. Synergy projects should enable substantial advances at the frontiers of knowledge, stemming, for example, from the cross-fertilization of scientific fields, from new productive lines of enquiry, or new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines. The transformative research funded by Synergy Grants should have the potential of becoming a benchmark on a global scale. Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigators must also demonstrate that their group can successfully bring together the scientific elements necessary to address the scope and complexity of the proposed research question. One of the Principal Investigators must be designated as the Corresponding Principal Investigator. At any one time, one Principal Investigator per Synergy Grant Group except the Corresponding one can be hosted or engaged by an institution outside of the EU or Associated Countries. Size of ERC Synergy Grants Synergy Grants may be awarded up to a maximum of EUR 10 000 000 for a period of 6 years. The maximum award is reduced pro rata temporis for projects of a shorter duration. This does not apply to ongoing projects. Profile of the ERC Synergy Grant Principal Investigators The 'Synergy Grant Group' applying for the ERC Synergy Grant must be made up of a minimum of two and a maximum of four Principal Investigators with competitive track records and, as necessary, their teams. Each of the Principal Investigators must present in the proposal a Curriculum Vitae and a Track Record as appropriate to their career stage. For further information, please see the ERC Work Programme 2026.

APPLICATION DEADLINE: 31 October 2025 This recognises young investigators in the field of paediatric infectious diseases. Both clinical and basic research is eligible. The winner will receive: 1. Euro 5,000 to be paid to the host institution for research purposes only. The host institution is not allowed to take any overhead on this amount (see declaration below) 2. At the time of being offered the award successful candidates will be invited to attend that year's ESPID Annual Meeting with registration, travel and accommodation being offered (if already registered, this will be refunded). Please be aware the travel and accommodation are subject to ESPID Rules and maximum amounts apply 3. The Young Investigator's medal 4. The winner will be asked to give a 5 minute presentation of their work at the ESPID Annual Meeting

Deadline for Submissions: November 1, 2025 The Prize aims to recognize researchers who have developed innovative advances with translational potential to impact women’s health globally. Contributions within any area of women’s health* will be considered. These may cover work in areas of female-specific conditions including maternal health and chronic gynecological diseases, reproductive health including contraception and infertility affecting all persons, or elucidation of sex- and gender-specific approaches to conditions that affect women differently or disproportionately. We encourage researchers who may have made significant advances in addressing questions in these fields at the intersection of translational research and clinical applications, or who are developing new drugs, diagnostic approaches, medical devices, or healthcare technologies, to apply. Researchers who have advanced development of new solutions that can be readily deployed in low- and middle-income countries are encouraged to apply. The Prize is awarded for outstanding research performed by the applicant and as described in a 1,000-word essay.